Skip to content
BillRazor
Generic J2597

DESMOPRESSIN AC 4 MCG/ML VIAL

DESMOPRESSIN AC 4 MCG/ML VIAL has a NADAC acquisition cost of $19.45, though hospitals typically charge significantly more than this wholesale price for the same generic medication.

By Michael Glenn , Healthcare Data Analyst · ·
Data from CMS files published FY 2024 CMS IPPS. Refreshed weekly.
About the analyst

Michael Glenn reviews CMS datasets and drug pricing at BillRazor Research. He focuses on NADAC acquisition costs and procedure coding accuracy. Expertise: drug pricing, NADAC data, CPT coding.

NADAC acquisition cost data
CMS drug pricing benchmarks
Updated 2026-04-03
Drug acquisition cost — DESMOPRESSIN AC 4 MCG/ML VIAL
NADAC cost$19.45 per unit
Hospital charges for this drug vary — typically 3–8x the acquisition cost. No observed hospital charge data is available for this specific drug.
$19.45
NADAC acquisition cost
INJECTABLE
Dosage form
INJECTION
Route

Desmopressin acetate injection treats diabetes insipidus and certain bleeding disorders by replacing a hormone that regulates water balance and blood clotting. This generic formulation typically charges 3-5x less than brand-name versions, creating significant billing variations across different pharmacy networks.

Check your bill amount
Enter the charge for DESMOPRESSIN AC 4 MCG/ML VIAL from your bill to compare against the NADAC acquisition cost.
$

No credit card required. Results in 60 seconds.

Research suggests 49–80% of hospital bills contain errors. Our system checks every line item against Medicare benchmarks.
Rates shown are from the 2026 Medicare Physician Fee Schedule and CMS IPPS. BillRazor compares your bill against these data sources. See how it works →

Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.

What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.

Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.

Upload your bill — free instant analysis